
Cadiprous 5mg Tablet
Marketer
Taj Pharma India Ltd
Salt Composition
Prasugrel (5mg)
Overview Cadiprous 5mg Tablet
Cardiogard 5mg tablets are antiplatelet agents, also known as blood thinners. They function by inhibiting harmful clot formation, ensuring smooth blood flow. This reduces the risk of recurrent heart attacks or strokes in patients with cardiac conditions. Cardiogard 5mg is indicated for individuals recovering from a recent heart attack, experiencing unstable angina, or post-stent placement. It mitigates the risk of future cardiovascular events, including recurrent heart attacks, stroke, and stent thrombosis. This medication is often prescribed concurrently with aspirin, another antiplatelet drug. It can be administered with or without food, consistently at the same time daily; continued use is crucial even with symptom improvement. Discontinuation may significantly raise the risk of cardiovascular events. The most frequent adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual flow. Wound healing may be prolonged. While usually self-limiting, persistent or concerning bleeding requires immediate medical attention. This medication is contraindicated in patients with active bleeding (e.g., peptic ulcer, intracranial hemorrhage), or severe hepatic impairment. Prior to initiation, disclose any history of bleeding disorders, recent significant trauma, or upcoming surgery to your physician. Temporary cessation may be necessary before elective procedures.
Primary Ingredients of Cadiprous 5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Cadiprous 5mg Tablet
Avoiding heart attacks and strokes
Major Benefits of Cadiprous 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Cadiprous tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Cadiprous 5mg Tablet:
- Bleeding
How to use Cadiprous 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Cadiprous tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
How Cadiprous 5mg Tablet works:
CardioGuard 5mg tablets offer antiplatelet protection. Their mechanism inhibits platelet aggregation, reducing the risk of dangerous blood clots. This, in turn, lessens the likelihood of recurrent stroke or myocardial infarction.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cadiprous 5mg Tablet presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
The safety of Cadiprous 5mg Tablet during pregnancy is unestablished. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Cadiprous 5mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Cadiprous 5mg Tablets.
KidneySAFE IF PRESCRIBED
Use of Cadiprous 5mg Tablet in patients with kidney impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Cadiprous 5mg Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Data regarding Cadiprous 5mg Tablet use in such patients is limited. Dosage alteration is unnecessary for those with mild to moderate liver dysfunction.
What if you forget to take Cadiprous 5mg Tablet :
Should you forget a Cadiprous 5mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Cadiprous 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperazine-based compound |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |
